MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Results from Pulmonary Hypertension Clinical Study
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released data from its HYPER-H21-3 human study. The company noted that data from its simulated pulmonary hypertension clinical study indicate positive safety and efficacy findings. Specifically, results show a tendency (p=0.1) during 15 minutes of simulated low levels of oxygen (hypoxia) for reduced pulmonary…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Featured in Latest Power Play Release
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), was spotlighted in an episode of the Power Play by the Market Herald. Cybin CEO Doug Drysdale talked with host Dave Jackson about the company’s recent positive results from its CYB004 pharmacokinetic study. The company announced that the study produced positive…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Completes SOC Certification Audit
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has completed the System and Organization Controls (“SOC”) 2 Type 2 certification audit. The audit, which started in November 2021, focused on controls relevant to the security trust services category. According to the announcement, SOC 2 Compliance is a recognized auditing standard developed by the…
-
MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Significant Advantages over IV and Inhaled DMT in Pharmacokinetic Study
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced positive preclinical data from a pharmacokinetic study evaluating its proprietary deuterated dimethyltryptamine (“DMT”) molecule, CYB004, delivered via inhalation. According to the announcement, inhaled CYB004 demonstrated significant advantages over both intravenous and inhaled DMT, including longer duration of action…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Marks Historic Week with Shipments of Uranium, Vanadium, REE
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, hit a critical mineral “trifecta” this month, making commercial shipments of uranium, vanadium and advanced rare earth materials — all in a single week. According to the announcement, the company shipped natural uranium concentrates (“U308”) to the Metropolis Works uranium conversion…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Update on Human Nicotine Study NIC-H22-1
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced details of human nicotine study NIC-H22-1, which is expected to begin dosing this summer. According to the announcement, NIC-H22-1 is a minimum 36-person human pharmacokinetic (“pk”) randomized, double blinded, cross-over study to compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Leading Cannabis Event
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced that CEO Luis Merchan will be presenting at the upcoming Benzinga Cannabis Capital Conference. The event is scheduled for April 20–21, 2022, in Miami, Florida. Merchan’s presentation is slated to begin at 3:20 p.m. ET on April…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate in Upcoming Virtual Investor Event
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be part of a moderated fireside chat during the Virtual Investor Glioblastoma Multiforme (“GBM”) Spotlight event on April 14, 2022. The chat is scheduled for 11:30 a.m. ET and…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Taking Diverse Product Portfolio to New Markets
Flora Growth Corp. (NASDAQ: FLGC) recently announced the successful import of Mambe CBD-containing food and beverage products into the United States from Colombia. The move capitalized on a new law signed by Colombian President Ivan Duque, which provides the necessary regulatory framework for cannabis product use and export. “Our team anticipated this regulatory update and…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Better Equips Itself for Long-Term Growth Plans
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, has promoted four employees to executive positions. Doris Lam has been named vice president of finance, Jason M Gonzalez has been named senior vice president of client development, Ronald J Gallegos has been named vice president of client experience…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Beginning of New Nicotine Formulation Creation, Evaluation Program
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to the announcement, the agreements call for Lexaria to provide specific DehydraTECH(TM) powder-based nicotine formulations for a fee; Altria in turn will evaluate the formulations. The new agreements will continue through March 31, 2023. Lexaria Bioscience’s…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names Seasoned Transactional Attorney to Board of Directors
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has named a new member of its board of directors. The company has appointed transactional lawyer Adele Hogan to the board; Hogan will replace Carl Williams. With more than three decades of experience, Hogan has been involved in an estimated $200 billion of securities, mergers,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hopes to Demonstrate DehydraTECH’s Superior Performance in Ongoing Epilepsy Research Program
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The research program will assess the seizure-inhibiting activity of cannabidiol (‘CBD’) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication…. The EPIL-A21-1 research program contains two main studies to be…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Further Strengthens Long-Term IP Position of Psychedelic-Based Programs
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that the World Intellectual Property Organization (“WIPO”) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (‘PCT’) patent application no.PCT/EP2021/077057). This further strengthens the company’s long-term intellectual property…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Deploys Proprietary ASR in North Carolina
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, continues to expand its footprint with its latest Knightscope K5 Autonomous Security Robot (“ASR”) contract. The company announced that it has deployed an ASR with a Fortune 500 company located in Charlotte, North Carolina. According to the announcement, the…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Upcoming Cannabis & Psychedelic Conference
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has announced that the Sequire Cannabis & Psychedelic Conference is scheduled for April 20, 2022, from 9 a.m. to 4 p.m. ET. The conference will be held via SRAX’s Sequire Virtual Events. The…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Closes on Asset Purchase Agreement of Merchant Account Portfolio
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced an acquisition that will bring significant processing volume portfolio in-house. The asset purchase agreement with Sky Financial & Intelligence, will enhance GBOX margins and create additional revenue-generating opportunities for the company. In the transaction, GreenBox purchased a portfolio of merchant accounts for $16 million in…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Brand Inks Distribution Deal to Launch CBD Products in Airports
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, and its newly acquired brand, Just CBD, have partnered with distribution company OTG Management to carry its CBD products in airports. The brand will initially be available in Houston’s George Bush Intercontinental/Houston Airport and Washington, DC’s Ronald Reagan Washington…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Present at BofA Securities Global Automotive Summit
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the BofA Securities Global Automotive Summit on April 13, 2022. According to the announcement, Cepton is scheduled to present at 1:20…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from France EC and ANSM Competent Authority for Potentially Pivotal Study of Berubicin
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced its receipt of approval from the National Agency for the Safety of Medicine and Health Products (“ANSM”) Competent Authority and from the People Protection Ethics Committee…
Search Articles
Latest Articles
- MissionIRNewsBreaks – The Wendy’s Company (NASDAQ: WEN) Reports Q3 Results, Highlights International Momentum and U.S. Operational Gains
- MissionIRNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Eyes Opportunity in Next Phase of the Digital Revolution
- Beeline Holdings Inc. (NASDAQ: BLNE) Reaches Cash-Flow Milestone as Growth Strategy Gains Traction
- Datavault AI Inc. (NASDAQ: DVLT) CEO Featured in Interview Highlighting Vision for Ethical, Accessible and Monetizable Artificial Intelligence
- MissionIRNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Sets Dec. 2 Conference Call to Discuss Solana Treasury Strategy